海旭医疗品牌怎么样 申请店铺

我要投票 海旭医疗在医疗用品行业中的票数:271 更新时间:2025-06-03
海旭医疗是哪个国家的品牌?「海旭医疗」是 日照海旭医疗器械有限公司 旗下著名品牌。该品牌发源于山东省日照市,由创始人王 *在2006年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力海旭医疗品牌出海!将品牌入驻外推网,定制海旭医疗品牌推广信息,可以显著提高海旭医疗产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

海旭医疗怎么样

日照海旭医疗器械有限公司,成立于2006年,位于美丽的海滨城市--日照,是一家专业生产械准字号的膏药生产厂家。目前以专业研发、生产和销售械准字号膏药为主要业务,是专业的膏药生产基地。

海旭医疗以市场为导向,高新技术为内涵,积极开发符合市场需求的产品。公司自创建以来先后投入资金,兴建起符合医疗器械生产质量管理规范的生产车间、质量检验控制室、仓库等设施,引进具有国际先进水平的生产设备,为生产“疗效好、见效快”的海旭牌系列产品提供了硬件保障;同时海旭医疗十分注重生产经营管理及专业技术人才的引进与培养,着力打造强有力的管理团队,为创建海旭品牌提供了软件保障。

海旭医疗主要生产暖宫贴、远红外理疗贴、磁疗贴、穴位敷贴、灸热贴、退热贴、烫熨治疗包、中医穴位透皮贴等医院临床和终端诊所系列产品。公司的经营范围有:骨科,妇科和小儿科等。经营品种高达数百种,经营方式有:代理和贴牌代加工。

针对目前市场上同类产品较多,竞争也比较激烈的情况,公司始终坚持务实、开拓、创新、发展的经营理念,不断创新贴膏生产工艺,同时注重绿色、环保、节能,致力打造“海旭”品牌,积极开拓市场发展空间,促使公司形成运作规范化、管理科学化、监控制度化、效益较大化的管理轨道。

海旭医疗秉承“科技的光芒源于人性设计,海旭的品牌源于产品品质”的经营理念。凭借过硬的产品质量,完整的产品结构,优秀的营销团队,宽阔的营销思路,灵活的营销体制,完善的售后服务,线上线下的推广力度,正逐步建立起覆盖全国的营销网络。


Rizhao Haixu Medical Equipment Co., Ltd., founded in 2006, is located in Rizhao, a beautiful coastal city. It is a plaster manufacturer specializing in the production of xizhun brand. At present, our main business is professional R & D, production and sales of xizhun plaster, which is a professional plaster production base. Haixu medical is market-oriented, high-tech oriented, and actively develops products that meet the market demand. Since its establishment, the company has invested in the construction of production workshops, quality inspection control rooms, warehouses and other facilities in line with the production quality management standards of medical devices, introduced internationally advanced production equipment, and provided hardware guarantee for the production of Haixu brand series products with "good effect and quick effect"; at the same time, Haixu medical attaches great importance to production management and professional technology The introduction and training of talents, and efforts to create a strong management team, provide software guarantee for the creation of Haixu brand. Haixu medical mainly produces warm palace paste, far-infrared physical therapy paste, magnetic therapy paste, acupoint application, moxibustion hot paste, antipyretic paste, ironing treatment package, traditional Chinese medicine acupoint transdermal paste and other hospital clinical and terminal clinic products. The business scope of the company includes: Orthopedics, gynecology and pediatrics, etc. There are hundreds of business varieties, including agency and OEM. In view of the current situation that there are many similar products and fierce competition in the market, the company always adheres to the business philosophy of pragmatism, exploration, innovation and development, constantly innovates the paste production process, pays attention to green, environmental protection and energy conservation, strives to build the brand of "Haixu", actively opens up the market development space, and promotes the company to form a standardized operation, scientific management and monitoring system A management track with high efficiency. Haixu medical adheres to the business philosophy that "the light of science and technology comes from human design, and the brand of Haixu comes from product quality". With excellent product quality, complete product structure, excellent marketing team, broad marketing ideas, flexible marketing system, perfect after-sales service, online and offline promotion, a nationwide marketing network is gradually established.

本文链接: https://brand.waitui.com/08710bf8c.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

建设银行获南向资金净买入9.76亿港元

南向资金今日净买入39.05亿港元。建设银行、美团-W、康方生物净买入额位列前三,分别获净买入9.76亿港元、7.59亿港元、6.87亿港元;盈富基金净卖出额居首,金额为19.39亿港元。(第一财经)

19分钟前

宇树科技经营范围新增出版物零售业务

36氪获悉,爱企查App显示,近日,杭州宇树科技股份有限公司日前发生工商变更,经营范围新增出版物零售。宇树科技股份公司成立于2016年8月,法定代表人为王兴兴,注册资本约259.42万元人民币,由王兴兴、汉海信息技术(上海)有限公司、宁波红杉科盛股权投资合伙企业等共同持股。

19分钟前

Spotify因数据保护违规被罚款5800万瑞典克朗

6月3日消息,瑞典斯德哥尔摩上诉法院声明称,因发现音乐流媒体平台Spotify未能按照欧盟《通用数据保护条例》的规定处理数据主体权利,法院裁定对Spotify处以5800万瑞典克朗的罚款。(界面)

19分钟前

端午假期,全国邮政快递业揽收快递包裹超15亿件

国家邮政局数据显示,端午假期,全国邮政快递业揽收快递包裹15.11亿件,同比增长19.4%。(央视新闻)

19分钟前

中信证券:向专业投资者发行不超150亿元科技创新公司债券获证监会批复

36氪获悉,中信证券公告,本公司收到中国证监会《关于同意中信证券股份有限公司向专业投资者公开发行科技创新公司债券注册的批复》。据此批复,公司可以向专业投资者公开发行面值总额不超过150亿元科技创新公司债券。此批复自同意注册之日起24个月内有效,公司在注册有效期内可以分期发行。

19分钟前

本页详细列出关于海旭医疗的品牌信息,含品牌所属公司介绍,海旭医疗所处行业的品牌地位及优势。
咨询